Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy

Kidney International

Volumn 68, Issue 1, 2005, Pages 167-172

  Xu, Li Xia ^a   Zhao, Ming Hui ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Glycosylation; IgA nephropathy; Pathology

Indexed keywords

AGGLUTININ; GLYCAN; IMMUNOGLOBULIN A1; LECTIN; N ACETYLGALACTOSAMINE; SIALIC ACID; GALACTOSE; IMMUNOGLOBULIN A; N ACETYLNEURAMINIC ACID;

ADULT; ARTICLE; BARK; BIOTINYLATION; BLOOD DONOR; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOSYLATION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOLECULE; PATIENT; PEANUT; PHENOTYPE; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; SIALYLATION; BIOPSY; BLOOD; HOSPITALIZATION; IMMUNOLOGY; KIDNEY; METABOLISM; PATHOLOGY;

ACETYLGALACTOSAMINE; ADULT; BIOPSY; FEMALE; GALACTOSE; GLOMERULONEPHRITIS, IGA; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN A; KIDNEY; MALE; N-ACETYLNEURAMINIC ACID; PHENOTYPE; SEVERITY OF ILLNESS INDEX;

EID: 24944496919     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00390.x     Document Type: Article

References (35)

1. DONADIO JV, GRANDE JP: Immunoglobulin A nephropathy: A clinical perspective. J Am Soc Nephrol 8:1324-1331, 1997
2. HIKI Y, TANAKA A, KOKUBO T, et al: Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Am Soc Nephrol 9:577-582, 1998
3. ALLEN AC, BAILEY EM, BARRATT J, et al: Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. J Am Soc Nephrol 10:1763-1771, 1999
4. HIKI Y, ODANI H, TAKAHASHI M, et al: Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 59:1077-1085, 2001
5. ALLEN AC, BAILEY EM, BRENCHLEY PE, et al: Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients. Kidney Int 60:969-973, 2001
6. WANG Y, ZHAO MH, LI XM, et al: Serum IgA1 from patients with IgA nephropathy induces phosphorylation of extracellular signal-regulated kinase and proliferation of human mesangial cells. Zhonghua Yi Xue Za Zhi 82:1406-1409, 2002
7. WANG Y, ZHAO MH, LI XM, et al: Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells. Clin Exp Immunol 136:168-175, 2004
8. KERR MA: The structure and function of IgA. Biochem J 271:285-296, 1990
9. SANO T, HIKI Y, KOKUBO T, et al: Enzymatically deglycosylated human IgA1 molecules accumulate and induce inflammatory cell reaction in rat glomeruli. Nephrol Dial Transplant 17:50-56, 2002
10. FLOEGE J, BURG M, KLIEM V: Recurrent IgA nephropathy after kidney transplantation: Not a benign condition. Nephrol Dial Transplant 13:1933-1938, 1998
11. KOKUBO T, HIKI Y, IWASE H, et al: Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J Am Soc Nephrol 9:2048-2054, 1998
12. MILAN T, MATOUSOVIC K, JULIAN BA, et al: Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 52:509-516, 1997
13. MILAN T, NOVAK J, JULIAN BA, et al: Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104:73-81, 1999
14. YASUDA Y, HORIE A, ODANI H, et al: Application of mass spectrometry to IgA nephropathy: Structural and biological analyses of underglycosylated IgA1 molecules. Contrib Nephrol 141:170-188, 2004
15. HASHIM OH, SHUIB AS, CHUA CT: The interaction of selective plant lectins with neuraminidase-treated and untreated IgA1 from the sera of IgA nephropathy patients. Immunol Invest 30:21-31, 2001
16. HIKI Y, IWASE H, SAITOH M, et al: Reactivity of glomerular and serum IgA1 to jacalin in IgA nephropathy. Nephron 72:429-435, 1996
17. IWASE H, TANAKA A, HIKI Y, et al: Aggregated human serum immunoglobulin A1 induced by neuraminidase treatment had a lower number of O-linked sugar chains on the hinge portion. J Chromatography B 724:1-7, 1999
18. COPPO R, AMORE A, ROCCATELLO D, et al: IgA antibodies to dietary antigens and lectin-binding IgA in sera from Italian, Australian and Japanese IgA nephropathy patients. Am J Kidney Dis 17:480-487, 1991
19. KOKUBO T, HASHIZUME K, IWASE H, et al: Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy. Nephrol Dial Transplant 15:28-33, 2000
20. BASSET C, DEVAUCHELLE V, DURAND V, et al: Glycosylation of immunoglobulin A influences its receptor binding. Scand J Immunol 50:572-579, 1999
21. HAAS M: Histologic subclassification of IgA nephropathy: A clinicapathologic study of 244 cases. Am J Kidney Dis 29:829-842, 1997
22. ALLEN AC, HARPER SJ, FEEHALLY J: Galatcosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 100:470-474, 1995
23. MATTU TS, PLEASS RJ, WILLIS AC, et al: The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fc alpha-receptor interactions. J Biol Chem 273:2260-2272, 1998
24. GREER MR, BARRATT J, HARPER SJ, et al: The nucleotide sequence of the IgA1 hinge region in IgA nephropathy. Nephrol Dial Transplant 13:1980-1983, 1998
25. COPPO R, AMORE A: Aberrent glycosytion in IgA nephropathy (IgAN). Kidney Int 65:1544-1547, 2004
26. IWASE H, KATSUMATA T, ITOH A, et al: Detection of enriched Thomsen-Friedenrich antigen on IgA1 from IgA nephropathy patients. J Nephrol 15:703-708, 2002
27. LEUNG JC, TANG SC, LAM MF, et al: Charge-dependent binding of polymeric IgA1 to human mesagial cells in IgA nephropathy. Kidney Int 59:277-285, 2001
28. KOKUBO T, HIKI Y, IWASE H, et al: Exposed peptide core of IgA1 hinge region in IgA nephropathy. Nephrol Dial Transplant 14:81-85, 1999
29. KOKUBO T, HIKI Y, IWASE H, et al: Evidence for involvement of IgA1 hinge glycopeptide in the IgA1-IgA1 interaction in IgA nephropathy. J Am Soc Nephrol 8:915-919, 1997
30. NIKOLOVA E-B, MILAN T, RUSSELL M-W: The role of the carbohydrate chains in complement (C3) fixation by solid-phase bound human IgA. Immunology 82:321-332, 1994
31. HIKI Y, KOKUBO T, IWASE H, et al: Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J Am Soc Nephrol 10:760-769, 1999
32. CHEN A, CHEN WP, SHEU LF, et al: Pathogenesis of IgA nephropathy: In vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretion. J Pathol 173:119-126, 1994
33. FUJII K, MULLER KD, CLARKSON AR, et al: The effect of IgA immune complexes on the proliferation of cultured human mesangial cells. Am J Kidney Dis 16:207-210, 1990
34. HARADA K, AKAI Y, KURUMATANI N, et al: Prognostic value of urinary interlukin 6 in patients with IgA nephropathy: An 8-year follow-up study. Nephron 92:824-826, 2002
35. ARRIZABALAGA P, SOLE M, ABELLANA R, et al: Tubular and interstitial expression of ICAM-1 as a marker of renal injury in IgA nephropathy. Am J Nephrol 23:121-128, 2003